EU OKs J&J $21B Buy Of Synthes, Pendi...

EU OKs J&J $21B Buy Of Synthes, Pending Sale of DePuy Orthopaedics

There are 4 comments on the International Business Times story from Apr 19, 2012, titled EU OKs J&J $21B Buy Of Synthes, Pending Sale of DePuy Orthopaedics. In it, International Business Times reports that:

Johnson & Johnson secured approval for its $21.3 billion purchase of Synthes Inc.

Join the discussion below, or Read more at International Business Times.

Gregory Fraser

Philadelphia, PA

#1 Apr 27, 2012
Really? Is this true? Why do you think J&J is getting rid of DePuy orthopaedics? I think there is a reason behind. I hope it will be unconvered anytime soon.
Lavinia Burtea

Bucharest, Romania

#2 Apr 29, 2012
Hello, so why JNJ is getting rid of DePuy? Well, isnt this an concession for the European Antitrust Comission? As i was reading these days, JNJ will sell DePuy to Biomet for 200 and something milion $. That is a great strategy for JNJ, they got Synthes which is much more stonger in the market, has more brevets and it will generate more profit by the sinergy effect. In my opinion this is a new conglomerat, but good for them, were very smart.
Eddie V

Tampa, FL

#3 May 15, 2012
In relation to this, hip problems are a growing concern worldwide. Good thing that DePuy Hip Replacement Recall has finally been implemented by its manufacturer, Johnson&Johnson (J&J). J&J have been charged with numerous lawsuits by their clients, legal specialists say. They were the ones affected by the failures and defects (e.g. fractures, displacements, loosening) of DePuy devices. See for related discussion
Jane Kane

West Chicago, IL

#4 Aug 23, 2012
It's a good thing that J&J has getting rid of DePuy Orthopaedics but I hope that they will still take responsibility to all the patients who have been harmed by DePuy's defective hip replacement implant. Many are hoping that Synthes Inc. will be far more good than DePuy and that they will submit to all regulations to promote efficient and safe-guarded products. You may refer to for more information.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News a CDC ban on 'fetus' and 'transgender?' Experts... 13 hr Wondering 92
News Merck grants free license for pediatric HIV drug (Feb '15) Dec 29 Seniors for Fairness 2
News Merck beats 1Q profit views with tight cost con... (May '16) Dec 29 Seniors for Fairness 2
News CDC banned from using words like fetus, transge... Dec 22 Trump is a joke 3
News a CDC ban on 'fetus' and 'transgender?' Experts... Dec '17 Imprtnrd 54
News Most actively traded companies on the TSX Dec '17 Joe 1
News Viagra goes generic: Pfizer to launch own littl... Dec '17 He Querried 1
More from around the web